The Company previously sponsored a shareholder-approved stock incentive plan (the “2015 Plan”) that provided for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, stock awards, and other stock-based and stock-related awards to directors, officers and other key associates. On May 20, 2020, the Company’s shareholders approved a new stock incentive plan (“the 2020 Plan”). The 2020 Plan provides for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance share units, dividend equivalent rights, and other stock-based and stock-related awards to directors, employees, or contractors of the Company, as determined by the Compensation Committee of the Board of Directors. The 2020 Plan provides for 1,635,000 newly reserved shares plus the 736,578 shares previously available for grant under the 2015 Plan.

Stock-based compensation expense recognized and included in “Selling, general and administrative expenses” in the condensed consolidated statements of operations, and related tax impacts were as follows:

	12 Weeks Ended						40 Weeks Ended
(In thousands)	October 3, 2020			October 5, 2019			October 3, 2020			October 5, 2019
Restricted stock	$	1,033		$	637		$	5,279		$	6,735
Income tax benefit		(289	)		(163	)		(564	)		(1,148	)
Stock-based compensation expense, net of tax	$	744		$	474		$	4,715		$	5,587

The following table summarizes activity in the Plans for the 40 weeks ended October 3, 2020:

					Weighted
		Restricted			Average
		Stock			Grant-Date
		Awards			Fair Value
Outstanding at December 28, 2019	$		928,733		$	20.28
Granted			501,934			15.90
Vested			(366,746	)		21.85
Cancelled/Forfeited			(45,512	)		16.39
Outstanding at October 3, 2020	$		1,018,409		$	17.73

As of October 3, 2020, total unrecognized compensation cost related to non-vested restricted stock awards granted under the Company’s stock incentive plan is $7.0 million and is expected to be recognized over a weighted average period of 2.6 years.